• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design.

作者信息

Romaguera Rafael, Salinas Pablo, Brugaletta Salvatore, Gomez-Lara Josep, Díaz José F, Romero Miguel A, García-Blas Sergio, Ocaranza Raymundo, Borde Pascual, Jiménez Kockar Marcelo, Millan Segovia Raul, Íñiguez Andrés, Alameda Mar, Trillo Ramiro, Lee Dae Hyun, Martín Pedro, López-Benito María, Frutos Araceli, Moreu José, Hernández-Hernández Felipe, García Del Blanco Bruno, Roura Gerard, Rossello Xavier, Pocock Stuart J, Fernández-Ortiz Antonio, Sabate Manel, Gómez-Hospital J A

机构信息

Hospital de Bellvitge - IDIBELL, University of Barcelona, Barcelona, Spain.

Hospital Clínico San Carlos and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

出版信息

Am Heart J. 2020 Apr;222:174-182. doi: 10.1016/j.ahj.2020.01.018. Epub 2020 Jan 28.

DOI:10.1016/j.ahj.2020.01.018
PMID:32087418
Abstract
摘要

相似文献

1
Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design.糖尿病第二代药物洗脱支架（SUGAR）试验：原理与研究设计。
Am Heart J. 2020 Apr;222:174-182. doi: 10.1016/j.ahj.2020.01.018. Epub 2020 Jan 28.
2
Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.在猪冠状动脉再狭窄模型中，新一代西罗莫司洗脱支架与氟聚合物依维莫司洗脱支架相比的类似血管反应。
Cardiol J. 2016;23(6):657-666. doi: 10.5603/CJ.2016.0108.
3
Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial.在接受经皮冠状动脉介入治疗的患者中，西罗莫司洗脱Orsiro支架与生物雷帕霉素洗脱Nobori支架的随机对照研究：斯堪的纳维亚临床结局随机试验组织VII试验的原理与研究设计
Am Heart J. 2015 Aug;170(2):210-5. doi: 10.1016/j.ahj.2015.05.009. Epub 2015 May 22.
4
One-year outcomes of percutaneous coronary intervention with the 38-mm Resolute zotarolimus-eluting stent.38mm 雷帕霉素洗脱钴基合金 Resolute 支架经皮冠状动脉介入治疗一年的结果。
Am J Cardiol. 2013 Nov 1;112(9):1335-41. doi: 10.1016/j.amjcard.2013.06.012. Epub 2013 Aug 14.
5
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.紫杉醇洗脱球囊后扩张与依维莫司洗脱支架治疗裸金属支架：使用光学相干断层成像术在 6 个月随访时的前瞻性随机研究。
Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4.
6
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.SPIRIT IV 试验 2 年随访结果：XIENCE V 依维莫司洗脱支架和 Taxus Express2 紫杉醇洗脱支架治疗边支血管被拘禁患者的疗效评估。
Am J Cardiol. 2013 Jun 1;111(11):1580-6. doi: 10.1016/j.amjcard.2013.01.330. Epub 2013 Mar 15.
7
Late restenosis following placement of a sirolimus eluting stent for in-stent restenosis.西罗莫司洗脱支架置入治疗支架内再狭窄后的晚期再狭窄。
Heart Lung Circ. 2007 Feb;16(1):50-1. doi: 10.1016/j.hlc.2006.08.004. Epub 2006 Dec 29.
8
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design.阿姆斯特丹研究者发起的 Absorb 策略全纳者试验（AIDA 试验）：一项比较 ABSORB 依维莫司洗脱生物可吸收血管支架治疗策略与 XIENCE 家族（XIENCE PRIME 或 XIENCE Xpedition）依维莫司洗脱冠状动脉支架治疗策略在连续全纳者治疗冠状动脉病变中的疗效和性能的临床评估：原理和研究设计。
Am Heart J. 2014 Feb;167(2):133-40. doi: 10.1016/j.ahj.2013.09.017. Epub 2013 Oct 17.
9
Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial.雷帕霉素洗脱支架与依维莫司洗脱支架治疗初发长冠状动脉病变患者的比较：一项随机LONG-DES VI试验
Coron Artery Dis. 2019 Jan;30(1):59-66. doi: 10.1097/MCA.0000000000000680.
10
Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.载有雷帕霉素的金属雷帕霉素洗脱支架经血管外涂层生物可降解聚合物：新型超薄西罗莫司支架与比马前列素支架在 DESTINY 随机试验中的血管造影和临床比较。
Cardiovasc Ther. 2015 Dec;33(6):367-71. doi: 10.1111/1755-5922.12159.

引用本文的文献

1
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.Amphilimus- 与 zotarolimus- 洗脱支架在合并糖尿病的冠状动脉疾病患者中的应用：SUGAR 试验。
Eur Heart J. 2022 Mar 31;43(13):1320-1330. doi: 10.1093/eurheartj/ehab790.
2
Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups.在所有患者人群中，使用超亲水性可降解聚合物涂层西罗莫司洗脱支架的临床转归：T-FLEX 注册研究包括高危亚组的 1 年结果。
Anatol J Cardiol. 2021 Oct;25(10):706-715. doi: 10.5152/AnatolJCardiol.2021.78291.
3
Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus : Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial.
无聚合物与新型持久聚合物新一代药物洗脱支架在伴或不伴糖尿病的冠状动脉疾病患者中的 10 年临床结局：冠状动脉支架置入术和血管造影结果的测试功效：西罗莫司和普罗布考及佐他莫司洗脱支架（ISAR-TEST 5）试验。
Clin Res Cardiol. 2021 Oct;110(10):1586-1598. doi: 10.1007/s00392-021-01854-7. Epub 2021 Jun 22.
4
Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.糖尿病患者永久聚合物或无聚合物支架植入后的临床结局：ReCre8 糖尿病子研究。
Catheter Cardiovasc Interv. 2022 Feb;99(2):366-372. doi: 10.1002/ccd.29685. Epub 2021 Apr 3.